The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
Clinical trial NCT00511823 · COMPLETED
Trial details
- NCT number
- NCT00511823
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-23
- Primary completion
- 2007-09-21
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.